Audrey Gabelle

Also affiliated with Université de Montpellier, Centre Hospitalier Universitaire de Montpellier, Institute for Neurosciences of Montpellier

MedicineChemistryBiochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification”.

Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification

Alzheimer s Research & Therapy(2020)10.1186/s13195-020-00596-4

N/A

0.833DataRank · unranked

257 citations

Randall J. Bateman, Christophe Hirtz, Philippe Marin, François Bécher, Chihiro Sato +3 more

MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology

Annals of Clinical and Translational Neurology(2021)10.1002/acn3.51435

N/A

0.457DataRank · unranked

20 citations

Nipun Mallipeddi, Nupur Ghoshal, Brenton A. Wright, Gregory S. Day, Albert A. Davis +6 more

Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals

medRxiv(2020)10.1101/2020.06.02.20119578

N/A

0DataRank · unranked

1 citations

Julien Dumurgier, Xavier Ayrignac, Cécilia Marelli, Daniel Alcolea, Juan Fortea +13 more

Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals

Alzheimer s Research & Therapy(2020)10.1186/s13195-020-00696-1

N/A

0DataRank · unranked

65 citations

Julien Dumurgier, Xavier Ayrignac, Cécilia Marelli, Daniel Alcolea, Juan Fortea +13 more

CSF tau microtubule-binding region identifies pathological changes in primary tauopathies

Nature Medicine(2022)10.1038/s41591-022-02075-9

N/A

0DataRank · unranked

94 citations

Nicolas R. Barthélemy, Salvatore Spina, Lawren VandeVrede, Yingxin He, Ross W. Paterson +17 more

Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer’s disease: relevance for precision medicine in neurodegenerative diseases

Ageing Research Reviews(2022)10.1016/j.arr.2022.101819

N/A

0DataRank · unranked

42 citations

Andrea Vergallo, Stefan Teipel, Pablo Lemercier, Filippo Sean Giorgi, Audrey Gabelle +9 more

Plasma Hepcidin as a potential informative biomarker of Alzheimer disease and vascular dementia

Alzheimer s Research & Therapy(2025)10.1186/s13195-025-01696-9

N/A

0DataRank · unranked

10 citations

Daniel Alcolea, Germain U. Busto, Audrey Gabelle, Xavier Ayrignac, Karim Bennys +12 more